Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt, page-2

From an investor's point of view we shouldn't be worried as the recent newsletter pointed out that all goes to plan at this stage but of course there could be some further delays depending on restrictions.

3-6 or even 12 months wouldn't bother me as IMU is not to blame for that, although some known posters will twist the facts and call it LC's and PH's incompetence.

But it will, as stated in the article, mean the difference for many between life and death. More people suffer and die from cancer than corona and yet, that little bastard gets all the attention.

The latest OV tweet should be worth an ASX Ann's as it is the 2nd IMU tech that proves the ability not just to cure but to prevent cancer due to the immune system's LT memory / recognising ability.

T- cell tech proved the immune system can kill cancer cells, B-tech and OV prove the immune system itself can produce the antibodies and can prevent it from occurring / reoccuoring.

2018 / 2019 T-cell and first generation OV tech deals were valued from $ US 200m to several billions, B- cell tech and latest generation OV deals will easily top that. IMU's MC is about AUD 115m, about $US 70m.. Even a primary student can work out the maths but not the majority of Uni graduates dealing with share investments on a daily basis.

GLTA